TUBERCULOSIS RELIEF USING SAFFRON OPTIONS

Pretomanid is getting tested as Section of a mix routine which includes moxifloxacin and PZA for the treatment of both drug-vulnerable and drug-resistant tuberculosis (ClinicalTrials.gov identifier: NCT02193776). Bedaquiline, authorized via the US FDA for treatment of multidrug-resistant tuberculosis in 2012, can be being investigated in drug-susce